Robotic management of large stone disease: a case series

J Robot Surg. 2020 Dec;14(6):855-859. doi: 10.1007/s11701-020-01060-z. Epub 2020 Mar 5.

Abstract

The gold standard for urologic management of large stone disease traditionally has been percutaneous nephrolithotomy (PCNL). An alternative to PCNL is robotic pyelolithotomy (RP), which continues to gain traction. This study is a retrospective review of ten cases performed over a 2 year period presenting operative outcomes for large stone disease treated with RP. The mean and standard deviation were calculated for age, body mass index, stone volume, stone diameter, pre-operative creatinine, operative time, robot-docked time, length of stay, post-operative creatinine, and estimated blood loss. In addition, results were collected for post-operative complications and secondary procedure requirements. Complete stone clearance was successful in 9 of 10 cases. The average renal function remained stable from a pre-operative creatinine of 0.917 mg/dL to a post-operative creatinine level of 0.943 mg/dL. This case series demonstrates that robotic assisted surgery has practical application when managing large stone disease.

Keywords: Percutaneous nephrolithotomy; Robotics; Staghorn calculi.

MeSH terms

  • Blood Loss, Surgical
  • Creatinine / blood
  • Female
  • Humans
  • Kidney Calculi / surgery*
  • Kidney Pelvis / surgery*
  • Lithotripsy / methods*
  • Male
  • Nephrolithotomy, Percutaneous / methods
  • Operative Time
  • Postoperative Complications
  • Retrospective Studies
  • Robotic Surgical Procedures / methods*
  • Staghorn Calculi / surgery
  • Treatment Outcome

Substances

  • Creatinine